Evaluation of the anti-diabetic drug sitagliptin as a novel attenuate to SARS-CoV-2 evidence-based in silico: molecular docking and molecular dynamics.
José Ednésio da Cruz FreireJosé Edvar Monteiro JúniorDaniel Pascoalino PinheiroGrayce Ellen da Cruz Paiva LimaCamila Lopes do AmaralVictor Rezende VerasMayara Ponte MadeiraErika Bastos Lima FreireRenan Galvão OzórioVirginia Oliveira FernandesAna Paula Dias Rangel MontenegroRaquel Carvalho MontenegroJeová Keny Baima ColaresRenan Magalhães Montenegro JúniorPublished in: 3 Biotech (2022)
The online version contains supplementary material available at 10.1007/s13205-022-03406-w.